EMA Issues Guidance for Drug Shortage Prevention Under New Pharmaceutical Legislation

The European Medicines Agency (EMA) has released comprehensive guidance for pharmaceutical manufacturers on drug shortage prevention plans. This initiative, part of upcoming pharmaceutical legislation and the Critical Medicines Act, aims to identify supply chain vulnerabilities and implement measures to mitigate or prevent future drug shortages, ensuring medication availability for patients.